A unique case of tardive dystonia induced by short-term therapy with perazin.
Perazin is a piperazine derivative of phenothiazine with higher affinity for the D2 than the D1 receptor. We observed a 43-year-old woman who developed blepharospasm and oral hyperkinesia as a tardive dystonic syndrome after short-term treatment with perazin. She had never taken any other neuroleptic medication and all known forms of secondary dystonia were ruled out. We were unable to find any previous reports of perazin-induced tardive dystonia.
Lohmann
T
T
Department of Psychiatry, University of Aachen, Germany.
Ferbert
A
A
Ebel
H
H
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001764:Blepharospasm / Q000139:chemically induced; D004421:Dystonia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008538:Meige Syndrome / Q000139:chemically induced / Q000523:psychology; D010464:Perazine / Q000009:adverse effects* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000150:complications / Q000188:drug therapy; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D010464:Perazine